Difference between revisions of "Stop-tranylcypromine"

From Psychiatrienet
Jump to: navigation, search
(Created page with '{{Drugswitch | from = tranylcypromine | stop = {{StopAlgemeen}} * 60 mg/day: :*'''Day 1:''' reduce dosage of tranylcypromine to 50 mg/day. :*'''Day 8:''' reduce dosage of tranyl...')
(No difference)

Revision as of 13:28, 6 May 2010

Tranylcypromine
Type Antidepressant
Group MAO-I
links
Medscape Tranylcypromine
PubChem 5530
PubMed Tranylcypromine
Kompas (Dutch) Tranylcypromine
Wikipedia Tranylcypromine


Nietinrijdenbord.png Stop tranylcypromine
  • In general after long-term maintenance treatment, the best is to reduce the dose by about 25% every 4-6 weeks. An apt pharmaceutical dose (tablet, capsule, mixture) is not always available. In these cases one should be creative with dosing.[1][2]
  • Another, more risky, possibility is being at a certain dose to use the following scheme:
  • 60 mg/day:
  • Day 1: reduce dosage of tranylcypromine to 50 mg/day.
  • Day 8: reduce dosage of tranylcypromine to 40 mg/day.
  • Day 15: reduce dosage of tranylcypromine to 30 mg/day.
  • Day 22: reduce dosage of tranylcypromine to 20 mg/day.
  • Day 29: reduce dosage of tranylcypromine to 10 mg/day.
  • Day 36: stop administration of tranylcypromine.



  1. The UK Drug and Therapeutics Bulletin; 1999;37:49-52
  2. Editor: please note that not all dosages are available in pharmacy. So now and then you should be creative.
The editors of psychiatrienet.nl take the greatest care to provide up-to-date and accurate information on this site. Nevertheless, mistakes and omissions cannot be entirely excluded. No rights devolve from the information provided. The editors and other providers of information to this site accept no responsibility for the content of this site or for the information provided therein; neither do they accept responsibility for possible damages which may derive from the use of the information on this site or from the linked sites. The editorial board accepts no responsibility for the content of the (linked) sites, for access to them, or for the products and services on these sites, nor for the occurrence of errors, viruses, and/or disruptions in service.